Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireSep 4 16:05 ET

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswireSep 4 08:00 ET

Chardan Adjusts PT on Solid Biosciences to $15 From $6, Updates Thesis Ahead of Data Release for Gene Therapy Candidate SGT-003; Maintains Buy Rating

MT NewswiresAug 19 05:39 ET

Express News | Solid Biosciences Inc : Chardan Capital Markets Raises Target Price to $15 From $6

ReutersAug 19 01:13 ET

Chardan Capital Maintains Solid Biosciences(SLDB.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsAug 17 18:32 ET · Ratings

Buy Rating Justified for Solid Biosciences Amid Promising Gene Therapy Advances

TipRanksAug 17 18:25 ET · Ratings